Key facts
- Notable investors include Creative Destruction Lab.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for MindMirror
- ·The full record, as it builds
Funding rounds
No funding rounds for MindMirror are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About MindMirror
Developer of a mobile artificial intelligence platform designed to assess concussion risk by analysing pupillary light reflex biomarkers. The company's platform offers non-invasive smartphone text and recovery monitoring tools which does not require a baseline test and specialised equipment, enabling athletes, clinicians, and trainers to detect brain injuries early, guide safe return to play and improve neurological outcomes.
- Sector
- Healthcare
- HQ
- Seattle, WA, United States
- Founded
- 2022
- Employees
- 5
- Website
- mindmirror.health/
- Ownership
- Privately Held (backing)
MindMirror doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in MindMirror shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on MindMirror in its N-PORT filings yet. We sweep new filings monthly.